Early administration of high-titre COVID-19 convalescent plasma prevents hospitalisation and death in immunocompromised ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback